R1	Has_index Arg1:T4 Arg2:T5	
*	OR T1 T2
R2	AND Arg1:T6 Arg2:T1	
R3	Has_multiplier Arg1:T6 Arg2:T3	
R4	Has_temporal Arg1:T6 Arg2:T4	
R5	Has_qualifier Arg1:T11 Arg2:T10	
*	OR T9 T11
R6	AND Arg1:T8 Arg2:T9	
R7	Has_temporal Arg1:T8 Arg2:T13	
R8	AND Arg1:T8 Arg2:T14	
R9	AND Arg1:T15 Arg2:T16	
*	OR T8 T15
R10	AND Arg1:T22 Arg2:T23	
*	OR T20 T24 T21 T25 T26 T28 T22
*	OR T18 T19
R11	Has_qualifier Arg1:T31 Arg2:T32	
R12	AND Arg1:T29 Arg2:T31	
R13	Has_temporal Arg1:T29 Arg2:T30	
R14	AND Arg1:T28 Arg2:T29	
R15	Subsumes Arg1:T18 Arg2:T20	
*	OR T34 T36 T35
R16	Has_temporal Arg1:T35 Arg2:T38	
R17	Has_temporal Arg1:T34 Arg2:T37	
R18	Has_qualifier Arg1:T39 Arg2:T40	
R19	Has_qualifier Arg1:T42 Arg2:T41	
*	OR T43 T44
R20	Has_temporal Arg1:T45 Arg2:T43	
R21	AND Arg1:T51 Arg2:T49	
R22	Has_value Arg1:T49 Arg2:T50	
R23	Has_qualifier Arg1:T48 Arg2:T47	
R24	Subsumes Arg1:T48 Arg2:T51	
*	OR T42 T48 T55 T54 T57 T58 T56 T45
R25	Subsumes Arg1:T39 Arg2:T42	
R26	Has_multiplier Arg1:T62 Arg2:T61	
R27	Has_negation Arg1:T64 Arg2:T65	
R28	AND Arg1:T62 Arg2:T64	
R29	Has_qualifier Arg1:T62 Arg2:T63	
R30	Has_qualifier Arg1:T69 Arg2:T68	
R31	AND Arg1:T67 Arg2:T69	
R32	AND Arg1:T66 Arg2:T67	
*	OR T62 T66
*	OR T72 T74 T73
*	OR T70 T71
R33	AND Arg1:T70 Arg2:T72	
T1	Drug 21 33	enzalutamide
T2	Drug 37 56	abiraterone acetate
T3	Multiplier 57 70	for > 14 days
T4	Temporal 71 90	prior to enrollment
T5	Reference_point 80 90	enrollment
T6	Procedure 6 15	treatment
T8	Procedure 137 149	chemotherapy
T9	Condition 154 162;172 178	prostate cancer
T10	Qualifier 166 171	other
T11	Condition 172 178	cancer
T13	Temporal 179 204	within the past 12 months
T14	Condition 210 237	residual cognitive deficits
T15	Procedure 253 265	chemotherapy
T16	Condition 270 275	mCRPC
T17	Non-representable 277 402	Patients/physicians planning treatment with chemotherapy during the 12 month period of the investigation are also ineligible.
T18	Condition 415 435	cognitive impairment
T19	Condition 415 424;439 450	cognitive dysfunction
T20	Condition 475 483	dementia
T21	Condition 485 504	Alzheimer's disease
T22	Condition 506 512	stroke
T23	Condition 518 545	residual cognitive deficits
T24	Condition 547 568	cognitive dysfunction
T25	Condition 591 606	substance abuse
T26	Condition 580 587;601 606	alcohol abuse
T28	Condition 611 632	cognitive dysfunction
T29	Procedure 650 659	treatment
T30	Temporal 644 649	prior
T31	Condition 668 674	cancer
T32	Qualifier 664 667	any
T34	Condition 693 700	seizure
T35	Condition 721 736	recurrent falls
T36	Condition 747 763	brain metastases
T37	Temporal 701 708	history
T38	Temporal 710 720	history of
T39	Condition 987 1007	intercurrent illness
T40	Qualifier 974 986	Uncontrolled
T41	Qualifier 1039 1051	uncontrolled
T42	Condition 1052 1060	diabetes
T43	Temporal 1062 1069	ongoing
T44	Qualifier 1073 1079	active
T45	Condition 1080 1089	infection
T47	Qualifier 1091 1102	symptomatic
T48	Condition 1103 1127	congestive heart failure
T49	Measurement 1129 1155	New York Heart Association
T50	Value 1156 1172	Class III and IV
T51	Condition 1173 1186	heart failure
T54	Condition 1189 1213	unstable angina pectoris
T55	Condition 1215 1233	cardiac arrhythmia
T56	Condition 1238 1257	psychiatric illness
T57	Condition 1258 1275	social situations
T58	Condition 1276 1291	substance abuse
T61	Multiplier 1381 1387	second
T62	Condition 1388 1398	malignancy
T63	Qualifier 1363 1379	currently active
T64	Condition 1410 1435	non-melanoma skin cancers
T65	Negation 1399 1409	other than
T66	Condition 1634 1655	cognitive dysfunction
T67	Procedure 1667 1676	treatment
T68	Qualifier 1680 1687	another
T69	Condition 1688 1698	malignancy
T70	Drug 1771 1795	psychotropic medications
T71	Drug 1799 1812	illicit drugs
T72	Condition 1822 1837	alter cognition
T73	Condition 1822 1827;1839 1852	alter concentration
T74	Condition 1822 1827;1857 1865	alter behavior
T77	Non-representable 1867 2062	Appropriate treatment by a licensed provider with medications for depression or anxiety, including but not limited to SSRIs, SNRIs, and standard dose benzodiazepines at a stable dose, is permitte
